Calcitonin and bone diseases

Reginster, Jean-Yves ; Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé

Language :

English

Title :

Publication date :

1992

Journal title :

The Lancet

ISSN :

0140-6736

eISSN :

1474-547X

Publisher :

Little, Brown and Co

Volume :

339

Pages :

1064-1065

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 25 November 2013

Statistics

Number of views

41 (3 by ULiège)

Number of downloads

1 (1 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

Bibliography

Nicholson, Moseley, Sexton, Mendelsohn, Martin (1986) Abundant calcitonin receptors in isolated rat osteoclasts. biochemical and autoradiographic characterization. J Clin Invest 78:355-360.
Reginster, Denis, Albert (1987) 1-year controlled randomised trial of prevention of early postmenopausal bone loss by intranasal calcitonin. Lancet 2:1481-1483.
Overgaard, Riis, Christiansen, Hansen (1989) Effect of salcatonin given intranasally on early postmenopausal bone loss. Br Med J 299:477-479.
Meunier, Delmas, Chaumet-Riffaud (1990) Intranasal salmon calcitonin for prevention of postmenopausal bone loss a placebo controlled study in 109 women. Osteoporosis 1990 , C. Christiansen, K. Overgaard, Osteopress, Copenhagen; 1861-1867.
MacIntyre, Stevenson, Whitehead, Wimalawansa, Banks, Healy (1988) Calcitonin for prevention of postmenopausal bone loss. Lancet 1:900-902.
Reginster (1991) Effects of calcitonin on bone mass and fracture rates. The American Journal of Medicine 91:19-22.
Gruber, Ivey, Baylink (1984) Long-term calcitonin therapy in postmenopausal Osteoporosis. Metabolism 33:295-303.
Mazzuoli, Passen, German (1986) Effects of salmon calcitonin in postmenopausal osteoporosis a controlled double-blind study. Calcif Tissue Int 38:3-8.
Overgaard, Hansen, Hers Nielsen, Christiansen (1990) Discontinuous calcitonin treatment of established osteoporosis: effect of withdrawal of treatment. Am J Med 89:1-6.
Rico, Hernandez, Revilla, Gomez-Castresana (1992) Salmon calcitonin reduces vertebral fracture rate in postmenopausal crush fracture syndrome. Bone Miner 16:131-138.
Reginster, Denis, Albert (1987) 1-year controlled randomised trial of prevention of early postmenopausal bone loss by intranasal calcitonin. Lancet 2:1481-1483.
Overgaard, Riis, Christiansen, Hansen (1989) Effect of salcatonin given intranasally on early postmenopausal bone loss. Br Med J 299:477-479.
Meunier, Delmas, Chaumet-Riffaud (1990) Intransal salmon calcitonin for prevention of postmenopausal bone loss: a placebo-controlled study in 109 women. Osteoporosis, 1990 , C. Chnstiansen, K. Overgaard, Osteopress, Copenhagen; 1861-1867.
Overgaard, Rus, Christiansen (1989) Nasal calcitonin for treatment of established osteoporosis. Clin Endocrinol 30:435-442.